The acquisition expands Stryker’s neurosurgery portfolio, adding Nico’s BrainPath and Myriad products, according to a Sept. 20 news release.
Earlier in September, Stryker finalized its acquisition of care.ai.
Stryker completes acquisition of neurosurgery company
Stryker completed its acquisition of Nico Corp., a company focused on minimally invasive tumor and intracerebral hemorrhage procedures.
